Liver News and Research

RSS

Eating grapes may reduce the risk of fatty liver disease

In a recent study published in the journal Foods, eating grapes can extend life expectancy by five years and reduce non-alcoholic fatty liver disease risk in mice fed high-fat diets.

17 Aug 2022

New method helps identify which gut microbes most likely contribute to inflammatory diseases

Cedars-Sinai investigators have developed a method to help identify which human gut microbes are most likely to contribute to a slew of inflammatory diseases like obesity, liver disease, inflammatory bowel disease, cancer and some neurological diseases.

17 Aug 2022

Researchers create novel mouse model for mapping protein communication between organs

Our many different organ systems are in constant communication with each other. During exercise, for example, muscles send out signals to fat and liver tissue to release their energy sources.

17 Aug 2022

Oral chlorophyllin supplement alleviates inflammatory bowel disease

The dietary supplement chlorophyllin alleviates inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, according to researchers from the Center for Diabetes and Metabolism Research at Sichuan University in China and from Cedars Sinai Medical Center in Los Angeles.

17 Aug 2022

Machine learning models can predict posttreatment recurrence in patients with early-stage hepatocellular carcinoma

According to ARRS' American Journal of Roentgenology (AJR), machine learning models applied to presently underutilized imaging features could help construct more reliable criteria for organ allocation and liver transplant eligibility.

17 Aug 2022

UW cardiologists employ catheter-delivered device to retrieve a benign tumor from the heart

Interventional cardiologists at the UW Medicine Heart Institute in Seattle recently performed a first-in-human procedure, successfully employing a catheter-delivered device to retrieve a benign tumor from inside a patient's heart.

17 Aug 2022

Experts assert the need to amplify "food first" and "no needle" messages among all athletes

Intravenous (IV) nutrition, which used to be considered a treatment of 'last resort', is threatening to become the norm for competitive athletes, despite no scientific evidence that it works or that it is safe, warn experts in an editorial, published online in the British Journal of Sports Medicine.

17 Aug 2022

Peter Adams and Bing Ren receive NIH grant to join multi-institution initiative studying the aging process

Peter Adams, Ph.D., and Bing Ren, Ph.D., have been awarded a new grant from the National Institutes of Health (NIH) to join a multi-institution initiative studying the process of aging.

16 Aug 2022

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

Inventia Life Science and Xylyx Bio today announced their strategic partnership following promising results developing more realistic, scalable, and reproducible 3D cell cultures for drug discovery and biomedical research.

From Inventia Life Science 16 Aug 2022

What are the risk factors related to COVID-19-related hospitalization and mortality?

In a new study, researchers assessed the risk factors associated with COVID-19-related hospitalization or mortality.

16 Aug 2022

Next generation mRNA vaccines exhibit excellent protective and therapeutic effects

Researchers around the world have been working for years on developing vaccines against different types of cancer, but without much success. Now, Tufts School of Engineering researchers think they have found one that does work. They have devised a method of targeting cancer in mice with a vaccine that is so strong and precise, it eliminates tumors and even prevents their recurrence.

16 Aug 2022

Novel zoonotic Langya virus identified in China

Scientists discuss their discovery of the novel Langya henipavirus in eastern China.

11 Aug 2022

Researchers identify genes that become active when carotid plaque rupture leads to a stroke

Researchers at Ochsner Health and Tulane University School of Medicine have identified the genes that become active in carotid arteries when plaque rupture causes a stroke.

11 Aug 2022

Elevated acetate levels reprogram gut microbiota during alcohol intake

Chronic alcohol use is a major cause of liver damage and death: Approximately 30,000 persons in the United States die annually from alcoholic liver diseases, such as cirrhosis.

11 Aug 2022

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

The current study, published online in the journal JHEP Reports, looks at PFAS, which are endocrine disruptors and potential hepatotoxins.

11 Aug 2022

Smoking continues to be a leading cause of cancer-related death

A new study led by researchers at the American Cancer Society (ACS) reports nearly 123,000 cancer deaths, or close to 30 percent of all cancer deaths, were from cigarette smoking in the United States in 2019, leading to more than two million Person-Years of Lost Life (PYLL) and nearly $21 billion in annual lost earnings. These losses were disproportionately higher in states with weaker tobacco control policies in the South and Midwest. The results were published today in the International Journal of Cancer.

11 Aug 2022

How ultraprocessed foods affect gut microbiome and health

Researchers describe the association between the consumption of ultraprocessed foods and chronic medical conditions.

10 Aug 2022

New CDC Vital Signs report: Few people diagnosed with hepatitis C receive timely treatment

A new CDC Vital Signs report finds that too few people diagnosed with hepatitis C are being treated, despite availability of medications capable of curing this viral infection.

10 Aug 2022

EPA action boosts grassroots momentum to reduce toxic ‘forever chemicals’

The intake pumps that once drew 6 million gallons of water a day from the Oostanaula River now sit mostly dormant in this northwestern Georgia city.

10 Aug 2022

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

Recently, 'Long COVID' is becoming a significant issue worldwide. It refers to a variety of symptoms that persist over an extended period after the patient has recovered from a novel coronavirus infection (COVID-19). In many cases, it is unclear what causes Long COVID symptoms, and there is insufficient information regarding recovery time.

10 Aug 2022

Liver News and Research

Eating grapes may reduce the risk of fatty liver disease

New method helps identify which gut microbes most likely contribute to inflammatory diseases

Researchers create novel mouse model for mapping protein communication between organs

Oral chlorophyllin supplement alleviates inflammatory bowel disease

Machine learning models can predict posttreatment recurrence in patients with early-stage hepatocellular carcinoma

UW cardiologists employ catheter-delivered device to retrieve a benign tumor from the heart

Experts assert the need to amplify "food first" and "no needle" messages among all athletes

Peter Adams and Bing Ren receive NIH grant to join multi-institution initiative studying the aging process

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery

What are the risk factors related to COVID-19-related hospitalization and mortality?

Next generation mRNA vaccines exhibit excellent protective and therapeutic effects

Novel zoonotic Langya virus identified in China

Researchers identify genes that become active when carotid plaque rupture leads to a stroke

Elevated acetate levels reprogram gut microbiota during alcohol intake

What is the association between polyfluoroalkyl substance exposure and risk of non-viral hepatocellular carcinoma?

Smoking continues to be a leading cause of cancer-related death

How ultraprocessed foods affect gut microbiome and health

New CDC Vital Signs report: Few people diagnosed with hepatitis C receive timely treatment

EPA action boosts grassroots momentum to reduce toxic ‘forever chemicals’

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News